ABSTRACT A 37-d laying hen experiment was performed to determine the effect of Diamond V XPC LS (XPC LS , Diamond V Mills, Cedar Rapids, IA) during a subclinical Eimeria maxima infection on intestinal health and productivity. Two hundred and sixteen 18-wk-old Brown Nick laying hens were allocated to 24 litter pens based on a weight class system (9 hens/ pen). The trial was carried out as a 2 × 2 factorial design with XPC LS and E. maxima challenge as main factors. Birds were fed a corn/wheat-based mash prelayer diet from wk 18 to 20 (10.9 MJ/kg of AME and 13.7% CP) and a standard phase I layer diet from wk 20 to 24 (11.7 MJ/kg of AME and 15.3% CP) that were supplemented with XPC LS at the rate of 0 or 0.75 g/kg. Hens were orally inoculated on d 23 (22 wk of age) with either 1 mL of saline (not infected) or 10,000 sporulated E. maxima oocysts/bird in 1 mL of saline (infected).
INTRODUCTION
At the onset of lay, feed intake of laying hens often limits their ability to meet their nutrient requirements for egg production, resulting in a negative nutrient balance. This negative nutrient balance increases their susceptibility for (intestinal) pathogenic infections (McReynolds et al., 2006) . Coccidiosis is a disease of major importance in poultry production (Williams, 2005) . Fowl coccidia (Eimeria spp.) and their pathogenesis are well-documented (Long and Reid, 1982) . In practice, coccidiosis may vary in severity from subclinical to clinical, resulting in a reduction in feed intake, poor growth performance, and an adverse effect on feed efficiency (Williams, 2005) . Mansford and Sykes (1967) have calculated that approximately 70% of the poor weight gain of chickens infected with E. acervulina was caused by a lower feed intake but the remaining weight loss was caused by other factors, such as reduced activity of digestive enzymes (Enigk and Dey-Hazra, 1976; Major and Ruff, 1978a,b) and villus atrophy (Pout, 1967) , leading to decreased nutrient absorption.
In Europe, the number of hens housed in aviary systems is increasing, as cage systems are banned. Cagefree systems are also becoming more prevalent in the United States. Floor-housed hens are affected more frequently by intestinal disorders such as coccidiosis and chronic enteritis (De Bruijn et al., 2008) . They indicated that chronic enteritis is not limited to floorhoused laying hens, but also cage-housed layers are experiencing intestinal disorders. As medication use in producing laying hens is being minimized, because of potential residues in eggs, egg producers rely on nutritional measures to improve the resistance of layers against intestinal disorders.
Saccharomyces cerevisiae fermentation products are described in multiple literature reviews as modulators of the immune system and reducing the susceptibility of animals to infections. Recently, Ghosh et al. (2012) reported a positive effect of Saccharomyces cerevisae on humoral immune response against New Castle disease in broilers. Also in piglets, positive effects of a SacEfficacy of Saccharomyces cerevisiae fermentation product on intestinal health and productivity of coccidian-challenged laying hens M. Lensing ,* 1 J. D. van der Klis ,* I. Yoon , † and D. T. Moore † charomyces cerevisiae fermentation product have been reported. van der Peet-Schwering et al. (2007) demonstrated that weanling piglets fed Diamond V XPC LS (Diamond V Mills, Cedar Rapids, IA) showed better growth rate and feed efficiency than control animals and had similar effects as Avilamycin-fed piglets. Dietary supplementation of a Saccharomyces cerevisiae fermentation product has also been shown to improve feed efficiency, phosphorus utilization, and egg quality in poultry (Tangendjaja and Yoon, 2002) . It is also suggested that these products can be beneficial for maintaining a stable intestinal environment (van Heugten et al., 2003) and, more specifically, improve intestinal immunity (Jurgens et al., 1997) . Several studies have shown that various Saccharomyces cerevisiae fermentation products are able to decrease the number of pathogens in the gastrointestinal tract, thereby supporting gut integrity (Savage and Zakrzewska, 1997; Sonmez and Eren, 1999; Spring, 1999a,b; Spring et al., 2000; Iji et al., 2001) . Yeast cell walls contain β-glucans and mannan-oligosaccharides (MOS), which might also stimulate humoral immunity and immunoglobulin status (Davis et al., 2004) . Supplementing feed with a Saccharomyces cerevisiae fermentation product could be useful in supporting the immune system of young laying hens and alleviating the negative consequences of stress, during the onset of lay, on bird health and productivity. The following study was conducted to evaluate the efficacy of Diamond V XPC LS on intestinal health, productivity, and immunity of young laying hens challenged with Eimeria maxima.
MATERIALS AND METHODS

Birds and Housing
Two hundred sixteen Brown Nick laying hens (18 wk of age) were weighed individually and assigned to 24 litter pens (1 × 3 m; wood shavings; 9 birds per pen) based on a weight class system: First, the average weight of 15 hens with the lowest BW and of 15 hens with the highest BW was determined (based on selection by visual observation). Subsequently, the difference between minimum and maximum average weight was split in 6 weight classes and all hens were assigned to a weight class based on their individual BW. Hens with lower or higher BW than the minimum or maximum average were assigned to the lowest or highest weight class. Finally, hens were allotted to the litter pens per weight class. Hens were reared in a cage system and were not vaccinated against coccidiosis during the rearing period.
Feed and water were available for ad libitum consumption throughout the experiment using feed pans and nipple drinkers, except for a 10-h feed withdrawal before inoculation (d 23; 22 wk of age) and necropsies (d 30 and 34; 23 wk of age). These feed withdrawal periods comprised the daily 8-h night period. The first week after arrival, a lighting schedule of 13L:11D was used. Subsequently, the light period was increased by 1 h per week until a light schedule of 16L:8D was reached. Temperature was kept at approximately 20°C. Hens were not vaccinated during the trial. To prevent cross contamination after the experimental infection, 12 pens with infected hens were physically separated from those that were not infected by a plastic wall.
Experimental Design
Four treatments with 6 replicate pens (n = 6) were applied in a 2 × 2 factorial design with a Saccharomyces cerevisiae fermentation product (XPC LS , Diamond V Mills Inc., Cedar Rapids, IA) and coccidian challenge as main factors. Treatments included 2 noninfected groups (NINF) and 2 infected groups (INF) with or without dietary supplementation of XPC LS (0.75 g/kg). On d 23 (when the hens were 21.3 wk old), after a 10-h feed withdrawal, NINF hens received 1 mL of saline by oral gavage, whereas INF hens were inoculated with 10,000 sporulated E. maxima oocysts/ bird in 1 mL of saline. The Eimeria was a laboratory strain provided by the Central Veterinary Laboratory (Weybridge, UK). All strains have been rejuvenated approximately every half-year and were conserved as a suspension of sporulated oocysts at 2 to 8°C in a 2.5% (wt/vol) potassium dichromate solution until application (as described by Peek et al., 2009) . Birds were fed a corn/wheat-based mash prelayer diet from wk 18 to 20 (10.9 MJ/kg of AME and 13.7% CP, diets 1 and 2) and a standard phase I layer diet from wk 20 to 24 (11.7 MJ/kg of AME and 15.3% CP, diets 3 and 4, Table 1 ).
Lesion Scoring
On d 30 and 34 (7 and 11 d postinjection, dpi) 3 hens per pen were selected for postmortem coccidian lesion scoring in the jejunal segment of the small intestine. Birds were euthanized by an intravenous injection with T61 (Intervet International BV, Boxmeer, the Netherlands). All birds were scored blind; that is, the person scoring for lesions did not have knowledge of the bird's treatment. Lesion scoring was on a scale of 0 to 4, in which 0 was given to birds scored negative for E. maxima lesions, a score of 1 to 3 indicated an increased severity of lesions using the method of Johnson and Reid (1970) , and a score of 4 was for mortalities with more severe lesions. Based on lesion scoring, percentage of infected hens was calculated from the sum of all positive-scored birds divided by the total number of necropsied birds. By categorizing the severity of lesions, an average for lesion severity for all necropsied birds per treatment could be calculated.
Oocysts Per Gram Droppings
Twelve fresh fecal droppings were collected per pen on d 30, 34, and 37 (7, 11, and 14 dpi). Droppings were pooled per pen per treatment per day and homogenized. Counting of the number of oocysts per gram of droppings (OPG) was performed by a modification of the McMaster counting chamber technique of Hodgson (1970) . Briefly, a 10% (wt/vol) droppings suspension in a salt solution (151 g/L) was made. After shaking vigorously, 1 mL of the suspension was pipetted into 9 mL of saturated sodium chloride (311 g/L). After mixing again, a proportion of the latter suspension was run into the McMaster counting chamber and the oocysts were counted using 100 and 200× magnification.
Production Parameters
Feed intake and laying rate were recorded per replicate pen on a weekly basis and feed efficiency was calculated as feed per dozen eggs. Daily feed intake and laying rate were recorded from d 24 to 37 (1 and 14 dpi), because feed intake is often assumed to be correlated with the severity of infection. All parameters are presented as a mean of 6 replicates per treatment. All routine study activities, health disorders, and mortality (with its most probable cause) were recorded daily.
Immune Parameters
On d 24 (1 dpi), before BSA administration, 3 randomly chosen hens were marked (and one spare hen in case of mortality, marked with a different color) per replicate and were blood sampled via the wing vein to determine a baseline value for IgM and IgG. Subsequently, hens were immunized by injection of 1 mL of PBS containing 0 or 1 mg of BSA (Sigma-Aldrich Chemie BV, Zwijndrecht, the Netherlands) i.m. in the breast muscle to initiate a humoral immune response. On d 30 and d 37, the marked hens were blood sampled again to determine anti-BSA IgM and IgG levels. Blood samples were centrifuged and serum was collected and stored at −20°C until further processing. Antibody titers to administered BSA were determined by ELISA in serum samples on d 0 (before immunization), d 7, and d 14 after sensitization (performed at Catholic University Leuven in Belgium). Briefly, 96-well plates were coated with 150 μL of BSA (Sigma, 30 μg/ mL in bicarbonate buffer, pH 9.6) and incubated at 4°C overnight. After subsequent washing with PBST [PBS with 0.01% (vol/vol) Tween 20], serum samples were serially diluted (diluted 1:1, 1:10, 1:20, 1:40, 1:80, 1:160, 1:320, 1:640 for IgM and 1:50, 1:100, 1:200, 1:400, 1:800, 1:1,600, 1:3,200, 1:6,400 for IgG) and plates were incubated at room temperature for 1 h. Binding of antibodies to BSA antigen was detected using 1:5,000 diluted fluorescein-conjugated goat anti-chicken IgM and fluorescein-conjugated goat anti-chicken IgG. After washing, fluorescein-conjugated antibodies were detected in duplicate with a multi label counter (Victor, model 1420, Perkin Elmer, Waltham, MA).
The experimental set-up and all procedures were approved by the institute's Ethical Committee for Animal Experiments.
Statistical Analyses
Raw data were analyzed for outliers. Significant outliers (i.e., outside the range mean ± 2.5 × SD) were excluded from the data set. The incidence of coccidial lesions (% of affected birds) was analyzed by Fisher Exact test, whereas the severity of lesions, measurements on production performance, and other parameters were analyzed by ANOVA using Genstat statistical software (12th edition; VSN International, Hemel Hempstead, UK). Treatment means were compared by the least significant difference. The model was as follows:
where Y ijk is the response parameter, μ is the mean, Block i is the effect of block (i = 1 to 6), Challenge j is the effect of coccidian challenge (j = 1, 2; infected or not infected), Supplement k is the effect of supplement (k = 1, 2; with or without XPC LS ), Interaction jk is the interaction of Challenge × Supplement, and e ijk is the residual error.
Effects were considered significant at P < 0.05, whereas 0.05 ≤ P < 0.10 was considered to be a nearsignificant trend.
RESULTS
Lesion Scoring
A significant challenge effect on the percentage of INF hens and severity of lesions on d 30 (7 d postinfection; Table 2 ) has proven that the E. maxima infection was successful. Coccidian challenge resulted in a significantly higher (P < 0.05) percentage of hens scored positive for coccidiosis (81% vs. 0%), and lesions were more severe (0.9 vs. 0.0; P < 0.05). On d 30, supplementation of XPC LS tended to interact with the coccidian challenge (P < 0.10), reducing the severity of lesions from 1.1 to 0.8 in INF hens (Table 2 and Figure  1 ), whereas no effect of XPC LS on lesion score was observed in NINF hens because no lesions were found at d 30. Based on this outcome, a specific contrast analysis was done using infected birds only with and without Diamond V XPC LS supplementation, demonstrating a significant (P < 0.05) effect of Diamond V XPC LS on reducing lesion severity in challenged birds at d 30.
No significant (P ≥ 0.1) effect of E. maxima challenge or XPC LS supplementation was observed on coccidiosis incidence in hens on d 34 (11 dpi). Compared with d 30, birds in the INF treatments were partly recovered and the incidence was decreased from 81% to 14% (Table 2 ). However, cross contamination occurred in the NINF groups because 21% of these birds had E. maxima lesions on d 34. A significant (P < 0.05) effect of XPC LS supplementation on the severity of lesions was observed on d 34. Supplementation of Diamond V XPC LS significantly decreased the severity of lesion from 0.3 to 0.1 (Table 2) .
OPG Counts
The results of OPG are presented in Table 3 . The oocysts counts varied from 1,000 to 130,000 oocysts per gram of droppings on d 30 in the litter of the INF hens. However, oocysts were also found in the litter of the NINF hens, although no lesions were apparent by this time. On d 34, lesions were clearly shown in both INF and NINF hens. The INF hens showed a reduction in oocysts shedding on d 34, whereas NINF hens seemed to be at the peak of their first oocyst excretion. On d 36, oocyst excretion was reduced in both challenged groups. It should be noted that no relation was observed between the number of oocysts counted and the percentage of hens with lesions or the severity of lesions observed. 
Production Parameters
Feed intake (FI), laying rate (LR), egg weight (EW), and feed efficiency (FE) were significantly affected by the coccidian challenge (Table 4) 
Immunoglobulin Production
The IgG and IgM antibody titers to BSA were not affected by BSA challenge. Although levels of anti-BSA IgM increased over time, this was not significant (P ≥ 0.1) and was not affected by treatment. For anti-BSA IgG levels, no difference (P ≥ 0.1) was observed between d 0 (before BSA challenge) and d 7 and 14 after BSA administration (data not shown).
DISCUSSION
In the present study, supplementation of Diamond V XPC LS did reduce the incidence and severity of lesions caused by an E. maxima infection. However, it is not likely that XPC LS supplementation directly affected the coccidian oocysts, because no anticoccidian claims are described to our knowledge for Saccharomyces cerevisiae fermentation products. The OPG counts could have supported this thought, but OPG results did not correlate with the incidence of coccidial lesions nor the severity of infection (lesion scores). This lack of correlation is in accordance with other studies using OPG counts as a response parameter (Peek and Landman, 2003) , and therefore, results on OPG are not conclusive in the present study. It was hypothesized that Diamond V XPC LS would perform in a more indirect route, by balancing the immune system, rather than directly affecting oocysts of Eimeria themselves. The bird's metabolic response to an Eimeria infection is characterized by physiological changes, of which activation of the immune system is of most importance. Like mammals, birds have an innate and adaptive immune system. Innate immunity usually acts effectively without previous exposure to a pathogen and confers broad protection against a variety of pathogens (Kimbrell and Beutler, 2001 ). The adaptive immune response is selective and very effective against pathogens, mainly after a second exposure (memory). Both parts of immunity are essential for a successful defense. However, the nutritional costs of activating innate or adaptive immunity differ. The nutritional costs of the innate immune system are very low, but when activated, the costs for supporting the innate immune system are high with each exposure to a pathogen (Klasing, 2007) . Initiating this innate response results in a lower FI, reduced nutrient digestion and absorption, as well as changes in metabolism, resulting in a higher demand for nutrients. Although FI does not compensate for this higher nutrient requirement, nutrients are derived from the mobilization of muscle tissue, which negatively affects BW (gain). If the acute phase response, as part of the innate immune system, in livestock could be decreased via nutrition and modulated more toward the less costly adaptive response (Klasing, 2007) , this might result in better growth performance and FE during infection (Korver and Klasing, 1997) . It is known that Saccharomyces cerevisiae fermentation products support an antibody response. Savage and Zakrzewska (1997) reported an increase in plasma IgG and bile IgA in poults fed diets supplemented with 0.11% MOS. Ghosh et al. (2012) showed that broilers fed a Saccharomyces cerevisiaesupplemented diet exhibited a better humoral immune response against New Castle disease virus and was more persistent over time than the nonsupplemented treatment. Davis et al. (2004) observed modulation of the immune system after supplementation of the diet with phosphorylated mannans derived from Saccharomyces cerevisiae in piglets. However, in the present study, in laying hens, we failed to produce significant effects of XPC LS or coccidian challenge on antibody production after BSA immunization. Because no clear effect of XPC LS or coccidian challenge on OPG shedding or immune parameters measured were observed, positive effects observed in this trial may need to be explained by other immune parameters. Other studies in broiler chickens have shown changes in the immune system when fed XPC-derived products (Al-Homidan and Fahmy, 2007; El-Husseiny et al., 2008) . Another mode of action of XPC LS , which is also mentioned in literature and may need to be considered, is a direct effect of XPC LS on the intestinal tract.
It is therefore hypothesized that the positive effect of Diamond V XPC LS can be attributed to the characteristics of metabolites that are utilized by the intestinal tract for controlling a potential secondary bacterial infection. Diamond V XPC LS is based on fermentation metabolites that include a broad range of activities associated with intestinal health. These fermentation metabolites have been shown to have biological antioxidant and anti-inflammatory properties in vitro (Jensen et al., 2008) , which can be associated with improved intestinal health during a coccidian challenge. Previous studies have shown an increase in free radical production during Eimeria spp. infections (Allen, 1997a,b) and a decrease in activity of the bird's antioxidant system (Georgieva et al., 2006) . The use of products with antioxidant capabilities has been shown to decrease the severity of coccidian challenges (Jang et al., 2007; Wang et al., 2008 ). An increase in free radical production and an impairment of the antioxidant system is well known to be associated with tissue destruction (Lin et al., 2006; Yanai et al., 2008; Lin et al., 2009 ). Coccidiosis causes mucosal damage in the intestine which can facilitate pathogen growth in the intestine (Yegani and Korver, 2008) . It has been shown that oxidative stress caused by a coccidian infection may also be associated with inflammation of the tissues (Allen, 1997a ). Therefore, the decrease in severity of the coccidian challenge when hens were fed XPC LS in this study may partially be attributed to the antioxidant and anti-inflammatory properties of the product.
Saccharomyces cerevisiae is used in the fermentation during the production of XPC LS and will contain cell wall components. Adherence of the pathogenic microbes to the enterocyte cell wall is thought to be a prerequisite for the onset of infection (Gibbons and Van Houte, 1975) . Newman (1994) reported that the presence of dietary MOS in the intestinal tract removed pathogenic bacteria that could attach to the lumen of the intestine in this manner. As intestinal damage occurs following inoculation with live coccidial parasites, opportunistic clostridia often proliferate in the mucus generated by the damaged intestine (Williams, 2005) . It is known that Eimeria infections and their severity are associated with other bacteria in the intestinal tract (Williams, 2005) . Johansson and Sarles (1948) considered that bacteria, such as Clostridium perfringens and coliforms can be involved in the pathology of Eimeria. Other workers supported that observation specifically on E. tenella and E. brunetti (Oe and Arakawa, 1975) . In research done by our lab, it was observed that 10% of broilers challenged with E. maxima naturally developed necrotic lesions caused by Clostridium perfringens (data not shown). Kimura et al. (1976) showed that coccidiosis resulted in a proliferation of clostridia and enterobacteria (coliforms) and a decline in lactic acidproducing bacteria (Lactobacilli and Bifidobacteria).
Within these lines of thinking, it is hypothesized that the supplementation of XPC LS could have controlled a potential secondary bacterial infection after a coccidiosis inoculation by improving intestinal health. This could be accomplished by limiting the ability of pathogens to attach to enterocytes, improving antioxidant status of the bird and controlling inflammation during the infection. However, it is often difficult to be sure which is the predisposing infection in the case of coccidiosis and bacterioses but it might be possible that by improving intestinal health, gut integrity was less compromised and the coccidiosis infection was milder in XPC LS -supplemented treatments.
Conclusion
The results indicate that supplementation of Diamond V XPC LS can reduce gut damage (incidence and severity of lesions) caused by an E. maxima infection. No major effects of XPC LS on production performance or humoral immunity were noticed. Eimeria maxima challenge, however, did reduce overall production per-formance significantly and showed that daily feed intake is the most reliable parameter indicating deterioration of bird health.
